Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

eGene

2000 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer of bio-separation and detection tools. The company provider of sample and assay technologies for research in life sciences, applied testing and molecular diagnostics. It specializes in electrophoresis, microfluidics, liquid handling and automation genotyping DNA testing tools for the biological, microbial materials and life sciences testing industries. Its DNA HDA-GT12 system detects, quantifies, identifies and characterizes biological organisms and automates routine and non-routine laboratory and industrial procedures critical to productivity.

Formerly Known As
BioCal Technology
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Drug Discovery
Acquirer
Primary Office
  • 17841 Fitch
  • Irvine, CA 92614
  • United States

eGene Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore eGene‘s full profile, request access.

Request full access to PitchBook

eGene Executive Team (2)

Name Title Board
Seat
Contact
Info
Ming-Sun Liu Ph.D Chairman, President & Chief Executive Officer
Udo Henseler Chief Executive Officer